Integral Health Asset Management, LLC Magenta Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.36 - $1.59 $14,040 - $62,010	39,000 Added 10.34%	416,000 $166,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $61,401 - $101,847	48,731 Added 14.84%	377,000 $532,000
Q2 2022 Aug 03, 2022	BUY	$0.97 - $3.08 $123,450 - $391,988	127,269 Added 63.32%	328,269 $394,000
Q1 2022 May 12, 2022	BUY	$2.55 - $5.23 $283,050 - $580,530	111,000 Added 123.33%	201,000 $583,000
Q3 2021 Nov 12, 2021	BUY	$6.07 - $9.89 $91,050 - $148,350	15,000 Added 20.0%	90,000 $655,000
Q2 2021 Aug 30, 2021	SELL	$9.76 - $14.15 $732,000 - $1.06 Million	-75,000 Reduced 50.0%	75,000 $734,000
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $829,600 - $1.2 Million	85,000 Added 130.77%	150,000 $1.47 Million
Q1 2021 May 10, 2021	BUY	$7.66 - $13.38 $497,900 - $869,700	65,000 New	65,000 $770,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.